Industrial stabilizers caprylate and N‐acetyltryptophanate reduce the efficacy of albumin in liver patients
Jan Stange, Melanie Stiffel, Anne Goetze, Sabrina Strube, Juliane Gruenert, Sebastian Klammt, Steffen Mitzner, Sebastian Koball, Stefan Liebe, Emil Reisinger – 13 December 2010 – Liver failure is associated with an accumulation of toxic molecules that exert an affinity to albumin. Some of them have vasoactive activity. So far, albumin has been used as a plasma expander to improve the available circulating blood volume. However, recent studies have suggested that albumin is more effective than starch for this indication.